Dapagliflozin
NDC 42571-318, Dapagliflozin, tablet, from Micro Labs Limited.
- Product NDC
- 42571-318
- Status
- Listed
- Labeler
- Micro Labs Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211467
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42571-318 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DAPAGLIFLOZIN10 mg/1
Pharmacologic classes
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42571-318-10 | 42571031810 | 1000 TABLET in 1 BOTTLE (42571-318-10) |
| 42571-318-30 | 42571031830 | 30 TABLET in 1 BOTTLE (42571-318-30) |
| 42571-318-90 | 42571031890 | 90 TABLET in 1 BOTTLE (42571-318-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/5dc0e9df-3b45-4469-93fe-3d2eddbfe2b7
Use it
Look up 42571-318 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42571-318 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42571-318. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.